跳至主要内容
临床试验/NL-OMON54038
NL-OMON54038
招募中
不适用

Microvascular rarefaction in vascular cognitive impairment and heart failure -VCI - CRUCIAL-VCI

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 115 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
cerebral small vessel disease
发起方
Medisch Universitair Ziekenhuis Maastricht
入组人数
115
状态
招募中
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Observational invasive

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

入排标准

入选标准

  • Inclusion criteria for VCI:
  • VCI due to cSVD defined as:
  • o visiting a memory clinic or outpatient clinic Neurology;
  • o cognitive complaints;
  • o demonstration of a cognitive deficit: MoCA less than 26 or impairment in at
  • least 1 cognitive
  • domain in neuropsychological assessment
  • o imaging evidence of cerebral small vessel disease:
  • \- extensive leukoaraiosis on CT, or
  • \- (early) confluent WMH on MRI (Fazekas score \>\= 2\), or

排除标准

  • Exclusion criteria for both VCI and controls
  • Inclusion criteria are not met
  • Unwillingness or inability to give written consent
  • mentally incompetent (or reasonable doubt about competence) to give informed
  • Contraindications to MRI, among which: pacemaker, metallic foreign body,
  • claustrophobia, pregnancy, neurostimulator, other kinds of implanted devices or
  • insulin pump
  • Contraindications to gadolinium contrast agent used for MRI, among which
  • allergy or severe renal impairment (eGFR \<30 ml/min)
  • Other major neurological or psychiatric conditions affecting the brain and

结局指标

主要结局

未指定

相似试验